Detalhe da pesquisa
1.
Using machine learning models to predict HBeAg seroconversion in CHB patients receiving pegylated interferon-α monotherapy.
J Clin Lab Anal
; 36(11): e24667, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36181316
2.
The efficacy of addition of Tenofovir Disoproxil Fumarate to Peg-IFNα-2b is superior to the addition of Entecavir in HBeAg positive CHB patients with a poor response after 12 weeks of Peg-IFNα-2b treatment alone.
Int J Med Sci
; 17(10): 1458-1463, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32624702